Evergen Alignment Partners III Files Exempt Offering Notice
| Field | Detail |
|---|---|
| Company | Evergen Alignment Partners III, LP |
| Form Type | D |
| Filed Date | Mar 23, 2026 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $1, $1,000,000, $5,000,000, $1,000,001, $5,000,001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: exempt-offering, private-placement, capital-raise
TL;DR
**Evergen Alignment Partners III just filed a Form D, signaling they're raising money through an exempt offering.**
AI Summary
Evergen Alignment Partners III, LP, a Texas-incorporated entity, filed a Form D on March 23, 2026, indicating a notice of exempt offering of securities. This filing, under Section 3(c)(1) of the Investment Company Act, signals that the company is raising capital without needing to register with the SEC, likely targeting accredited investors. For existing or potential investors, this means the company is actively seeking funding, which could fuel growth or new projects, but also implies less public disclosure compared to registered offerings.
Why It Matters
This filing indicates Evergen Alignment Partners III, LP is raising capital, which could fund new investments or operations, potentially impacting future returns for investors.
Risk Assessment
Risk Level: medium — Exempt offerings typically involve less public disclosure, which can mean less transparency for investors.
Analyst Insight
An investor should research the specific terms of this exempt offering, if publicly available, and assess the company's investment strategy and management team before making any investment decisions.
Key Numbers
- 2026-03-23 — Filing Date (the date the Form D was filed and accepted by the SEC)
- 021-577385 — File No. (the SEC file number for this offering)
- 395032582 — EIN (the Employer Identification Number for Evergen Alignment Partners III, LP)
Key Players & Entities
- Evergen Alignment Partners III, LP (company) — the filer of the Form D
- 0002095063 (company) — the CIK of the filer
- Texas (company) — state of incorporation for the filer
Forward-Looking Statements
- Evergen Alignment Partners III, LP will successfully raise capital through this exempt offering. (Evergen Alignment Partners III, LP) — medium confidence, target: 2027-03-23
FAQ
What type of filing is this document?
This document is a Form D, which is a "Notice of Exempt Offering of Securities" filed by Evergen Alignment Partners III, LP.
When was this Form D filed and accepted by the SEC?
The Form D was filed and accepted on March 23, 2026, at 17:01:54.
Under which section of the Investment Company Act is this offering exempt?
This offering is exempt under Section 3(c)(1) of the Investment Company Act, as indicated by Item 3C.1 in the filing.
What is the business address of Evergen Alignment Partners III, LP?
The business address of Evergen Alignment Partners III, LP is 600 W. 5TH STREET #1200 AUSTIN TX 78701.
What is the CIK number for Evergen Alignment Partners III, LP?
The CIK number for Evergen Alignment Partners III, LP is 0002095063.
Filing Stats: 1,223 words · 5 min read · ~4 pages · Grade level 18.3 · Accepted 2026-03-23 17:01:54
Key Financial Figures
- $1 — enues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,
- $1,000,000 — No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,
- $5,000,000 — Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001
- $1,000,001 — e $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000
- $5,000,001 — $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
- $25,000,000 — $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001
- $25,000,001 — $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
- $50,000,000 — 5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,0
- $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $1
- $50,000,001 — 0,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 O
Filing Documents
- primary_doc.html (D)
- primary_doc.xml (D) — 6KB
- 0002095063-26-000001.txt ( ) — 7KB
From the Filing
Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Evergen Alignment Partners, LP Corporation Limited Partnership Limited Liability Company General Partnership Business Trust Other Name of Issuer Evergen Alignment Partners III, LP Jurisdiction of Incorporation/Organization TEXAS Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) 2025 Yet to Be Formed 2. Principal Place of Business and Contact Information Name of Issuer Evergen Alignment Partners III, LP Street Address 1 Street Address 2 600 W. 5TH STREET #1200 AUSTIN TEXAS 78701 512-515-3333 3. Related Persons Last Name First Name Middle Name EVERGEN MANAGEMENT, LLC - Street Address 1 Street Address 2 600 W. 5TH STREET #1200 AUSTIN TEXAS 78701 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) General Partner Last Name First Name Middle Name Marcus Morris Troy Street Address 1 Street Address 2 600 W. 5TH STREET #1200 AUSTIN TEXAS 78701 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Manager of General Partner 4. Industry Group Agriculture Banking & Financial Services Commercial Banking Insurance Investing Investment Banking Pooled Investment Fund Hedge Fund Other Investment Fund Private Equity Fund Venture Capital Fund *Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes No Other Banking & Financial Services Business Services Energy Coal Mining Electric Utilities Energy Conservation Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals Other Health Care Manufacturing Real Estate Commercial Construction REITS & Finance Residential Other Real Estate Retailing Restaurants Technology Computers Telecommunications Other Technology Travel Airlines & Airports Lodging & Conventions Tourism & Travel Services Other Travel Other 5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 Over $100,000,000 Decline to Disclose Decline to Disclose Not Applicable Not Applicable 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b) Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c)(14) Section 3(c)(7) 7. Type of Filing New Notice Date of First Sale 2026-03-06 First Sale Yet to Occur Amendment 8. Duration of Offering Does the Issuer intend this offering to last more than one year? Yes No 9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe) 10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? Yes No Clarification of Response (if Necessary) 11. Minimum Investment Minimum investment accepted from any outside investor $ 0 USD 12. Sales Compensation Recipient Recipient CRD Number None (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number None Street Address 1 Street Address 2 13. Offering and Sales Amounts Total Offering Amount $ 490750 USD Indefinite Total Amount Sold $ 490750 USD Total Remaining to be Sold $ 0 USD Indefinite Clarification of Response (if Necessary) 14. Investors Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering Regardless o